Arinnalifesciences.com

Vascular Biogenics Ltd (NASDAQ:VBLT) reported on September 17th 2015, that the complete Phase 2 data on VB-111 in combination with Bevacizumab (Avastin(TM)) will be presented at the European Society for Medical Oncology’s (ESMO) European Cancer Congress...

Maruti Pharma Pvt. Ltd., a speciality pharmaceutical company dedicated completely to dermatological care and manufacturing a wide range of dermatological medicines, is seeking for young, energetic, dynamic, socio-interactive, and result orientated qualified...

Ahmedabad-based drug maker, Intas Pharmaceuticals, today informed that the company has approached the Delhi High Court citing trademark violation by Arinna Lifesciences, and has got an ex-parte in...

Moneycontorl Bureau The meeting of Foreign Investment Promotion Board (FIPB) will be held on July 13. The board will consider 41 foreign direct investment (FDI) proposals. Proposals from companies like Glaxo Smithklin Pharmaceuticals, GlaxoSmithKline...

bidnessetcnews: Despite Amgen’s blockbuster patents nearing expiration, it has the potential to riposte with a competitive pipeline and drug profile Amgen is one of the few pharmaceutical companies to embrace biotechnology for the development of novel...